44 related articles for article (PubMed ID: 15057226)
1. Putting the heat on ALS.
Benn SC; Brown RH
Nat Med; 2004 Apr; 10(4):345-7. PubMed ID: 15057226
[No Abstract] [Full Text] [Related]
2. Arimoclomol, a coinducer of heat shock proteins for the potential treatment of amyotrophic lateral sclerosis.
Phukan J
IDrugs; 2010 Jul; 13(7):482-96. PubMed ID: 20582873
[TBL] [Abstract][Full Text] [Related]
3. Arimoclomol: a potential therapy under development for ALS.
Lanka V; Wieland S; Barber J; Cudkowicz M
Expert Opin Investig Drugs; 2009 Dec; 18(12):1907-18. PubMed ID: 19938902
[TBL] [Abstract][Full Text] [Related]
4. Clinical and experimental neuroprotection in neurodegenerative diseases is a therapeutic option for the future of amyotrophic lateral sclerosis (ALS). Preface.
Ludolph AC; Drory VE
J Neurol; 2000 Dec; 247 Suppl 6():VI/1. PubMed ID: 19714407
[No Abstract] [Full Text] [Related]
5. Treatment of amyotrophic lateral sclerosis - what is the next step?
Ludolph AC
J Neurol; 2000 Dec; 247 Suppl 6():VI/13-8. PubMed ID: 19714403
[TBL] [Abstract][Full Text] [Related]
6. [Amyotrophic lateral sclerosis: recent insights from transgenic animal models with SOD1 mutations].
Aoki M
Rinsho Shinkeigaku; 2004 Nov; 44(11):788-91. PubMed ID: 15651292
[TBL] [Abstract][Full Text] [Related]
7. Neuromuscular dysfunction in the mutant superoxide dismutase mouse model of amyotrophic lateral sclerosis.
Parkhouse WS; Cunningham L; McFee I; Miller JM; Whitney D; Pelech SL; Krieger C
Amyotroph Lateral Scler; 2008; 9(1):24-34. PubMed ID: 18273716
[TBL] [Abstract][Full Text] [Related]
8. Overexpressed mutant G93A superoxide dismutase protects calcineurin from inactivation.
Li S; Wang X; Klee CB; Krieger C
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):156-61. PubMed ID: 15193434
[TBL] [Abstract][Full Text] [Related]
9. Complex genetics of amyotrophic lateral sclerosis.
Kunst CB
Am J Hum Genet; 2004 Dec; 75(6):933-47. PubMed ID: 15478096
[No Abstract] [Full Text] [Related]
10. Neuroscience: Standard model.
Schnabel J
Nature; 2008 Aug; 454(7205):682-5. PubMed ID: 18685674
[No Abstract] [Full Text] [Related]
11. Can ketogenic diet slow progression of ALS?
Siva N
Lancet Neurol; 2006 Jun; 5(6):476. PubMed ID: 16739298
[No Abstract] [Full Text] [Related]
12. Minocycline for patients with ALS.
Carrì MT
Lancet Neurol; 2008 Feb; 7(2):118-9; author reply 120-1. PubMed ID: 18207105
[No Abstract] [Full Text] [Related]
13. Treatment of pseudobulbar affect in ALS.
Smith RA; Brooks BR
Lancet Neurol; 2005 May; 4(5):270. PubMed ID: 15847840
[No Abstract] [Full Text] [Related]
14. Amyotrophic lateral sclerosis: from disease mechanisms to therapies.
Bruijn LI
Biotechniques; 2002 May; 32(5):1112, 1114, 1116 passim. PubMed ID: 12019785
[No Abstract] [Full Text] [Related]
15. Increase in life expectancy for mice fed diethylhydroxylamine (DEHA).
Heicklen J; Brown E
J Gerontol; 1987 Nov; 42(6):674-80. PubMed ID: 3680886
[TBL] [Abstract][Full Text] [Related]
16. On action of 5-bromosalicylhydroxamic acid against drug resistance in tuberculosis.
HORNUNG S; AMALOWICZ F; BRODA Z; NECIUK-SZCZERBINSKI Z; PARYSKI E; POLONCZYK M; RAPF T
Br J Tuberc Dis Chest; 1958 Jan; 52(1):19-25. PubMed ID: 13499873
[No Abstract] [Full Text] [Related]
17. Putting heat on the ball .
Science; 1988 Oct; 242(4878):518. PubMed ID: 17815891
[No Abstract] [Full Text] [Related]
18. Heat shock protein 70: roles in multiple sclerosis.
Mansilla MJ; Montalban X; Espejo C
Mol Med; 2012 Sep; 18(1):1018-28. PubMed ID: 22669475
[TBL] [Abstract][Full Text] [Related]
19. Molecular chaperones in Parkinson's disease--present and future.
Ebrahimi-Fakhari D; Wahlster L; McLean PJ
J Parkinsons Dis; 2011; 1(4):299-320. PubMed ID: 22279517
[TBL] [Abstract][Full Text] [Related]
20. Changes in the regulation of heat shock gene expression in neuronal cell differentiation.
Oza J; Yang J; Chen KY; Liu AY
Cell Stress Chaperones; 2008; 13(1):73-84. PubMed ID: 18347944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
